Literature DB >> 9709870

Vancomycin-resistant Staphylococcus aureus: infection control considerations.

R P Wenzel1, M B Edmond.   

Abstract

The lessons of the antibiotic era are crystal clear: in the footrace between humans and microbes, the organisms' genetic repertoire and efficient response to environmental changes will win the day. New antibiotics are essential, but their shelf life will be enhanced only if used wisely and sparingly. The antibiotic era is continually threatened by inappropriate decisions regarding use, inappropriate choices, and unnecessary durations of treatment. In concert with improved prescribing habits, efforts to identify and isolate resistant organisms introduced from outside institutions are essential. Last, continual energy is needed to influence the behavior of health care professionals and to maintain optimal infection control policies and procedures. We remain optimistic about the ability of infectious diseases physicians to respond appropriately to continued microbial challenges with research, education, and wise practice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9709870     DOI: 10.1086/514646

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

1.  Prosthetic Joint Infection.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

2.  Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations.

Authors:  R L Akins; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a university hospital in northeastern Iran.

Authors:  Amir Azimian; Seyed Asghar Havaei; Hosein Fazeli; Mahmood Naderi; Kiarash Ghazvini; Siamak Mirab Samiee; Masoud Soleimani; Shahin Najar Peerayeh
Journal:  J Clin Microbiol       Date:  2012-08-29       Impact factor: 5.948

4.  Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period.

Authors:  P Villari; C Sarnataro; L Iacuzio
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  Daptomycin dose-effect relationship against resistant gram-positive organisms.

Authors:  Raymond Cha; Richard G Grucz; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

6.  Pharmacodynamics of oritavancin (LY333328) in a neutropenic-mouse thigh model of Staphylococcus aureus infection.

Authors:  Carole J Boylan; Kristina Campanale; Philip W Iversen; Diane L Phillips; Michael L Zeckel; Thomas R Parr
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

7.  In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model.

Authors:  R L Akins; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

8.  Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii.

Authors:  X Corbella; A Montero; M Pujol; M A Domínguez; J Ayats; M J Argerich; F Garrigosa; J Ariza; F Gudiol
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

9.  Nasal colonization of and clonal transmission of methicillin-susceptible Staphylococcus aureus among Chinese military volunteers.

Authors:  Fen Qu; Enbo Cui; Tongsheng Guo; Haijing Li; Suming Chen; Liming Liu; Wang Han; Chunmei Bao; Yuanli Mao; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

Review 10.  Vancomycin resistance in staphylococci.

Authors:  Arjun Srinivasan; James D Dick; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.